Xiaofang Zeng

Xiaofang Zeng


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2024 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
XZXiaofang Zeng
Xiaofang Zeng
JSJing Sun
Jing Sun
FLFamei Li
Famei Li
LPLiming Peng
Liming Peng
CZChenglong Zhang
Chenglong Zhang
XLXiangwei Liu
Xiangwei Liu
Aim: Mitochondrial homeostasis is essential for maintaining redox balance. Besides canonical autophagy, Rab9-dependent alternative mitophagy is a crucial mechanism in metabolic cardiomyopathy. Here, we aim to investigate the role of alternative mitophagy and Beclin 1 haploinsufficiency (Beclin 1+/-) in high-fat diet (HFD)-induced metabolic cardiomyopathy. Results: 24-week HFD impaired glucose tolerance and cardiomyocyte contraction in WT mice, both of which were rescued in Beclin 1+/- mice. Beclin 1 haploinsufficiency had little effect on the conventional autophagy mediators (ATG5, LC3II/LC3I) but further upregulated Rab9 expression, a marker of alternative autophagy, in response to HFD challenge. Furthermore, either the inhibition of alternative autophagy or Beclin 1 haploinsufficiency abolished palmitic acid-induced cardiomyocyte contractile anomalies. In vitro, palmitic acid over-activated mitophagy, resulting in decreased mitochondrial content in H9C2 cells. These aberrations were alleviated in cells deficient in alternative autophagy but not in cells deficient in conventional autophagy. Mechanistically, HFD promoted ROS production, activated Rab9-dependent alternative mitophagy, and inhibited mitochondrial biosynthesis. Beclin 1+/- rescued HFD-induced ROS overflow, mitochondrial biogenesis impairment, and prevented Rab9 translocation from the cytoplasm to the mitochondria, thereby inhibiting Rab9-mediated mitophagy over-activation. Innovation: For the first time, this study suggests that prolonged alternative mitophagy exacerbates chronic HFD-induced cardiac dysfunction and supports the protective role of Beclin 1 haploinsufficiency in metabolic cardiomyopathy. This provides additional evidence for a target-based pharmacological intervention. Conclusions: Beclin 1 haploinsufficiency protects against HFD-induced cardiac dysfunction by inhibiting Rab9-dependent alternative mitophagy and ROS production, while promoting mitochondrial biogenesis. Modulating Beclin 1 expression holds promise in preventing chronic HFD-related cardiomyopathy.

25 June 2024 in Heliyon
Verified
Journal Article
Open access
BLBenhui Liang
Benhui Liang
YTYiyang Tang
Yiyang Tang
QCQin Chen
Qin Chen
JZJiahong Zhong
Jiahong Zhong
BPBaohua Peng
Baohua Peng
LZlihuang zha
lihuang zha
The timing of central venous pressure (CVP) measurement may play a crucial role in heart failure management, yet no studies have explored this aspect. Clinical information pertaining to patients in critical condition with a diagnosis of heart failure was retrieved from the MIMIC-IV database. The association between initial measurements of central venous pressure (CVP) and the incidence of mortality from all causes was analyzed using the Cox proportional hazards approach. Subgroup analysis and propensity score matching were conducted for sensitivity analyses. This study included 11,241 participants (median age, 75 years; 44.70 % female). Utilizing restricted cubic spline and Kaplan–Meier survival analyses, it was determined that prognostic outcomes were better when CVP was measured within the initial 5-h window. Multivariate-adjusted 1-year (HR: 0.69; 95 % CI: 0.61–0.77), 90-day (HR: 0.70; 95 % CI: 0.62–0.80), and 30-day (HR: 0.67; 95 % CI: 0.57–0.78) all-cause mortalities were significantly lower in patients with early CVP measurement, which was proved robustly in subgroup analysis. Subsequent to the application of propensity score matching, a cohort of 1536 matched pairs was established, with the observed mortality rates continuing to be significantly lower among participants who underwent early CVP assessment. Early CVP measurement (within 5 h) demonstrated an independent correlation with a decrease in both immediate and extended all-cause mortality rates among patients in critical condition suffering from heart failure.

24 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YTYiyang Tang
Yiyang Tang
WLWenchao Lin
Wenchao Lin
LZlihuang zha
lihuang zha
XZXiaofang Zeng
Xiaofang Zeng
ZLZhenghui Liu
Zhenghui Liu
Zaixin YuZaixin Yu
Zaixin Yu
Background: Congestive heart failure (CHF) is a complex clinical syndrome, with high morbidity and mortality. Serum anion gap (SAG) has been known to be associated with the severity of various cardiovascular diseases. However, the role of SAG indicators in CHF is unclear. Methods and results: A retrospective analysis of data from MIMIC-III v1.4 was conducted in critically ill patients with CHF. Clinical information of each patient, including demographic data, comorbidities, vital signs, scores, and laboratory indicators, were successfully obtained. Cox proportional hazards models were performed to determine the relationship between SAG and mortality in CHF patient, the consistency of which was further verified by subgroup analysis. Results: A total of 7426 subjects met the inclusion criteria. In multivariate analysis, after adjusting for age, gender, ethnicity, and other potential confounders, higher SAG was significantly related to an increase in 30-day and 90-day all-cause mortality of critically ill patients with CHF compared with lower SAG (tertile3 vs tertile1: adjusted HR, 95% CI: 1.74, 1.46–2.08; 1.53, 1.32–1.77). In subgroup analysis, the association between SAG and all-cause mortality present similarities in most strata. Conclusion: SAG at admission can be a promising predictor of all-cause mortality in critically ill patients with CHF.

31 December 2024 in Archives of Medical Science
Verified
Journal Article
Open access
PDF file
XZXiaofang Zeng
Xiaofang Zeng
MJMukamengjiang Juaiti
Mukamengjiang Juaiti
YTYiyang Tang
Yiyang Tang
RWRuolong Wang
Ruolong Wang
DLDongliang Liu
Dongliang Liu

16 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YTYiyang Tang
Yiyang Tang
LZlihuang zha
lihuang zha
XZXiaofang Zeng
Xiaofang Zeng
YFYilu Feng
Yilu Feng
WLWenchao Lin
Wenchao Lin
Zaixin YuZaixin Yu
Zaixin Yu
Background: Acute myocardial infarction (AMI) is a common critical illness in the cardiovascular field, with poor prognosis. This study aimed to construct a nomogram to predict long-term survival of critically ill patients with AMI, which helps to assess severity, guide treatment, and improve prognosis. Methods and results: The clinical data of patients with AMI was extracted from the database MIMIC-III v1.4. The Cox proportional hazards models were performed to identify the independently prognostic factors, and a nomogram for predicting long-term survival of AMI patients was developed based on the multifactor analysis, of which discriminative ability and accuracy was evaluated by concordance index (C-index) and calibration curve. Results: A total of 1202 patients were included in the analysis, of which 841 were divided into the training set and 361 were the validation. Multivariate analysis shown that age, blood urea nitrogen, respiratory rate, SAPSII score, cardiogenic shock, cardiac arrhythmias, and respiratory failure served as the independently predictive factors, which were incorporated into the nomogram. Moreover, the nomogram shown favorable performance for predicting 4-year survival of AMI patients with the C-index of 0.788 [95% confidence interval (CI): 0.763 to 0.813] and 0.783 (95% CI: 0.748 to 0.818) in the training and validation set, respectively. Conclusion: The nomogram we constructed here can accurately predict the long-term survival of patients with AMI.